Ryan Specialty (NYSE:RYAN) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Ryan Specialty (NYSE:RYAN – Get Free Report) had its target price lifted by Morgan Stanley from $50.00 to $55.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley‘s price target points to a potential upside of 15.15% from the company’s previous close.

Several other analysts have also recently commented on RYAN. Mizuho boosted their price target on shares of Ryan Specialty from $40.00 to $48.00 and gave the stock a “neutral” rating in a research note on Friday. Cantor Fitzgerald raised their price objective on Ryan Specialty from $34.00 to $41.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Citigroup raised their price objective on Ryan Specialty from $50.00 to $53.50 and gave the company a “buy” rating in a research report on Monday, August 3rd. Royal Bank Of Canada reduced their target price on Ryan Specialty from $55.00 to $52.00 and set an “outperform” rating on the stock in a report on Friday, October 30th. Finally, JPMorgan Chase & Co. boosted their target price on Ryan Specialty from $39.00 to $45.00 and gave the stock an “underweight” rating in a research report on Monday, August 3rd. Eight research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Ryan Specialty currently has an average rating of “Hold” and a consensus target price of $52.91.

View Our Latest Stock Report on RYAN

Ryan Specialty Price Performance

Shares of Ryan Specialty stock traded up $0.87 on Monday, hitting $47.76. 78,469 shares of the company traded hands, compared to its average volume of 2,199,251. Ryan Specialty has a 52 week low of $29.28 and a 52 week high of $58.91. The business has a 50-day simple moving average of $41.17 and a 200 day simple moving average of $39.00. The company has a debt-to-equity ratio of 4.03, a quick ratio of 1.01 and a current ratio of 1.01. The stock has a market capitalization of $12.02 billion, a P/E ratio of 59.09, a price-to-earnings-growth ratio of 0.99 and a beta of 0.54.

Ryan Specialty (NYSE:RYAN – Get Free Report) last issued its earnings results on Thursday, October 29th. The company reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.02. The firm had revenue of $789.96 million during the quarter, compared to analyst estimates of $792.99 million. Ryan Specialty had a net margin of 8.25% and a return on equity of 47.77%. During the same quarter in the prior year, the business earned $0.47 earnings per share. Research analysts expect that Ryan Specialty will post 2.18 earnings per share for the current fiscal year.

Insider Buying and Selling at Ryan Specialty

In other news, CEO Benjamin Wuller sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $47.31, for a total transaction of $2,365,500.00. Following the transaction, the chief executive officer owned 94,095 shares of the company’s stock, valued at approximately $4,451,634.45. The trade was a 34.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 52.03% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Vancity Investment Management Ltd purchased a new stake in Ryan Specialty in the 2nd quarter worth about $621,000. Guardian Point Capital LP lifted its stake in Ryan Specialty by 15.0% in the first quarter. Guardian Point Capital LP now owns 575,000 shares of the company’s stock worth $19,400,000 after purchasing an additional 75,000 shares during the last quarter. Confluence Investment Management LLC boosted its position in shares of Ryan Specialty by 64.6% during the third quarter. Confluence Investment Management LLC now owns 311,140 shares of the company’s stock valued at $11,512,000 after buying an additional 122,139 shares during the period. Bank of America Corp DE boosted its position in shares of Ryan Specialty by 34.8% during the first quarter. Bank of America Corp DE now owns 1,508,083 shares of the company’s stock valued at $50,883,000 after buying an additional 389,505 shares during the period. Finally, Vulcan Value Partners LLC boosted its position in shares of Ryan Specialty by 20.0% during the second quarter. Vulcan Value Partners LLC now owns 7,912,669 shares of the company’s stock valued at $298,782,000 after buying an additional 1,317,334 shares during the period. 84.82% of the stock is owned by hedge funds and other institutional investors.

Ryan Specialty Company Profile

(Get Free Report)

Ryan Specialty is a specialty insurance organization that provides distribution, underwriting and related services to insurance brokers, agents and carriers. Its business includes wholesale brokerage, which helps insurance professionals place coverage for risks that may be difficult to insure in the standard market, and underwriting management services for specialty insurance products. The company works across a range of property and casualty insurance lines, including professional liability, transportation, property, casualty and other specialty risks.

Featured Articles

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.